GeneDx Holdings Corp. Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest
GeneDx Holdings Corp. (WGS) reported Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest of -$1.27 million for the 3-month period ending 2021-06-30, per its 10-Q filed 2021-07-21.
Discontinued › Shareholders' Equity
us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest · last filed 2021-07-21
- GeneDx Holdings Corp. net income (loss), including portion attributable to nonredeemable noncontrolling interest for the quarter ending 2021-06-30 was -$1.27M.
| Period end | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 6 month |
|---|---|---|
| 2021-06-30 | -$1.27M 10-Q · filed 2021-07-21 | -$45.46M 10-Q · filed 2021-07-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |